| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e16d1b3130c75f905199bb431589879 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-3468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14503 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14532 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-17 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 |
| filingDate |
2013-08-13^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-12-26^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efd88f97b0befae3890a2aa461d74c52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb603e7f69da49f7eeb55eac0cd77fcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39359e30e17f0e4f24b4569d49a0fe00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfbc6229205a989c72fd754b36c87943
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42375e8f67035f21442f1a09d06e80d5 |
| publicationDate |
2017-12-26^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9849239-B2 |
| titleOfInvention |
Generation and application of an insulin limit for a closed-loop operating mode of an insulin infusion system |
| abstract |
A controller for an insulin infusion device includes a processor device and a memory element that cooperate to provide a processor-implemented closed-loop insulin limit module. The insulin limit module is operated to obtain: a fasting blood glucose value of a user; a total daily insulin value of the user; and fasting insulin delivery data that is indicative of insulin delivered to the user during a fasting period. The insulin limit module calculates a maximum insulin infusion rate for the user based on the fasting blood glucose value, the total daily insulin value, and the fasting insulin delivery data. The maximum insulin infusion rate is applicable during a period of closed-loop operation of the insulin infusion device. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484652-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484651-B2 |
| priorityDate |
2012-08-30^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |